Cholangiocarcinoma

In a patient with obstructive jaundice and suspected cholangiocarcinoma, prioritize biliary decompression for acute cholangitis, hepatic decompensation that prevents oncologic therapy, or clinically consequential biliary obstruction. Endoscopic biliary drainage is the usual initial approach in Western practice; use percutaneous transhepatic biliary drainage when endoscopic drainage fails, is inadequate, or is not feasible. NatureNaturePrognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage | Scientific Reports

If the patient is clinically stable, obtain high-quality contrast-enhanced cross-sectional imaging before manipulating the biliary tree. Imaging defines tumor location, vascular involvement, liver remnant requirements, metastatic disease, and operative feasibility; it is specifically required for accurate staging and resectability assessment in perihilar and intrahepatic disease. BMJ+1BMJBritish Society of Gastroenterology guidelines for the diagnosis ... - GutScienceDirectHilar Cholangiocarcinoma: expert consensus statement

Route the case early to a hepatobiliary multidisciplinary team when imaging suggests potentially resectable disease. Complete resection remains the curative treatment option, whereas unresectable disease is managed with palliation, systemic therapy, and selected local or investigational approaches. Nature+1NatureCholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & HepatologyScienceDirectExtra-hepatic cholangiocarcinoma diagnosis: from classical pathological analysis to the emerging omics tests - ScienceDirect

Intrahepatic cholangiocarcinoma arises within the liver and is commonly evaluated as a hepatic mass requiring assessment of intrahepatic distribution, vascular anatomy, extrahepatic spread, and adequacy of future liver remnant before a resection decision. Multifocal intrahepatic disease creates a different problem from a solitary resectable lesion; comparative observational data have evaluated hepatic arterial infusion pump chemotherapy against resection in multifocal disease, underscoring that surgical selection cannot be based on histology alone. JAMA+1JAMAHepatic Arterial Infusion Pump Chemotherapy vs Resection for ...WileyAdvances in the treatment of intrahepatic cholangiocarcinoma: An ...

Perihilar cholangiocarcinoma requires especially detailed mapping of longitudinal biliary extension, portal and arterial relationships, and the future liver remnant. If resection is planned, major hepatectomy with bile duct resection and regional lymphadenectomy has been associated with a reported 26% actual 5-year survival in a surgical series. JAMA+1JAMAMajor Hepatic Resection for Hilar CholangiocarcinomaBMJBritish Society of Gastroenterology guidelines for the diagnosis ... - Gut

Distal cholangiocarcinoma is approached through the distal bile duct pathway, with attention to feasibility of transpapillary drainage and the operative implications of local extension. For resectable distal disease, routine preoperative biliary drainage is not mandatory; reserve it for acute cholangitis, intractable pruritus, bilirubin greater than 14.6 mg/dL, or an anticipated surgical delay beyond 4 weeks. NatureNatureCholangiocarcinoma 2026: status quo, unmet needs and priorities | Nature Reviews Gastroenterology & Hepatology

For suspected hilar cholangiocarcinoma, minimum diagnostic and staging evaluation includes CA 19-9 measurement and high-quality cross-sectional imaging, preferably before biliary intervention. Interpret CA 19-9 cautiously in obstructed patients because cholestasis can cause false-positive elevation; it should not independently establish malignancy. ScienceDirect+1ScienceDirectHilar Cholangiocarcinoma: expert consensus statementScienceDirectExtra-hepatic cholangiocarcinoma diagnosis: from classical pathological analysis to the emerging omics tests - ScienceDirect

Use ERCP-based brush cytology and tissue sampling when pathology will alter treatment selection or when a benign stricture remains plausible. Standard brush cytology and biopsy are limited by tumor desmoplasia, surrounding inflammation, sampling quality, and low sensitivity; reported sensitivities are approximately 45% for brush cytology and 48% for biopsy in extrahepatic cholangiocarcinoma. ScienceDirectScienceDirectExtra-hepatic cholangiocarcinoma diagnosis: from classical pathological analysis to the emerging omics tests - ScienceDirect

Escalate an unresolved, high-suspicion stricture to targeted sampling strategies rather than reassuring on negative brushing alone. Concurrent cholangioscopy can provide histologic sampling, and, in primary sclerosing cholangitis, the diagnostic approach integrates ERCP with brush cytology and fluorescence in situ hybridization, plus radiographic findings and CA 19-9 or CEA. BMJ+1BMJBritish Society of Gastroenterology guidelines for the diagnosis ... - GutWileyPathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis

In PSC-associated suspected cholangiocarcinoma, distinguish a dominant inflammatory or fibrotic stricture from malignancy through integrated imaging, ERCP-based sampling, cytology, and FISH rather than a single test result. Emerging DNA methylation assays have shown diagnostic signal in research cohorts but require broader prospective validation before replacing established pathways. Wiley+1WileyPathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitisWolters KluwerEarly and accurate detection of cholangiocarcinoma in... : Hepatology

Offer surgical evaluation to patients without unresectable local anatomy or distant disease on high-quality staging. For perihilar tumors, the curative-intent operation may require major partial hepatectomy, bile duct resection, and regional lymphadenectomy; operative planning should incorporate the functional future liver remnant and the need for preoperative drainage or augmentation. JAMA+1JAMAMajor Hepatic Resection for Hilar CholangiocarcinomaBMJBritish Society of Gastroenterology guidelines for the diagnosis ... - Gut

Use preoperative biliary drainage selectively rather than reflexively. In distal cholangiocarcinoma, drainage is recommended for acute cholangitis, intractable pruritus, bilirubin greater than 14.6 mg/dL, or surgery delayed more than 4 weeks; routine drainage in otherwise resectable distal disease is not mandatory. NatureNatureCholangiocarcinoma 2026: status quo, unmet needs and priorities | Nature Reviews Gastroenterology & Hepatology

For unresectable perihilar cholangiocarcinoma with biliary obstruction, pursue palliative stenting by ERCP or percutaneous transhepatic cholangiography and drainage. Endobiliary radiofrequency ablation and photodynamic therapy have been used individually to improve local tumor control and biliary strictures, but they should not substitute for systemic treatment selection or durable drainage planning. Nature+1NatureCholangiocarcinoma 2026: status quo, unmet needs and priorities | Nature Reviews Gastroenterology & HepatologyNatureImpact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy | Scientific Reports

For unresectable or metastatic biliary tract cancer, obtain comprehensive molecular profiling early enough to guide therapy at progression or when systemic options are being selected. Recommended testing includes MMR assessment by immunohistochemistry or PCR, HER2 assessment by immunohistochemistry with in situ hybridization for equivocal cases, and next-generation sequencing for FGFR2 fusions, IDH1 mutations, and NTRK alterations. Wolters KluwerWolters KluwerIntrahepatic cholangiocarcinoma: Insights on... : Hepatology Communications

If tissue is insufficient or prior operative or biopsy material is unavailable, circulating tumor DNA profiling is an alternative for identifying actionable alterations. A negative plasma result should be interpreted in clinical context because tumor-derived DNA detection can be limited; pursue tissue-based profiling when feasible and when a result would change treatment. Wolters KluwerWolters KluwerIntrahepatic cholangiocarcinoma: Insights on... : Hepatology Communications

Match subsequent therapy to the alteration and prior treatment course rather than treating cholangiocarcinoma as molecularly uniform. Molecularly selected options discussed for biliary tract cancer include pembrolizumab for dMMR tumors; HER2-directed approaches including trastuzumab plus pertuzumab, zanidatamab, trastuzumab deruxtecan, and tucatinib plus trastuzumab; and targeted therapy pathways for FGFR2 fusions, IDH1 mutations, and NTRK alterations. Wolters KluwerWolters KluwerIntrahepatic cholangiocarcinoma: Insights on... : Hepatology Communications

Continue to reassess biliary drainage during systemic treatment because obstruction can produce recurrent cholangitis, worsen cholestasis, and preclude oncologic therapy. In advanced extrahepatic disease, metal or plastic stents are used to maintain decompression and reduce obstructive cholangitis risk. Nature+1NatureImpact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy | Scientific ReportsNaturePrognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage | Scientific Reports